Dexamethasone implant in diabetic macular edema.
作者信息
Chhablani J
机构信息
Srimati Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Hyderabad Eye Research Foundation, Kallam Anji Reddy campus, LV Prasad Eye Institute, Hyderabad, India.
出版信息
Eye (Lond). 2016 Dec;30(12):1650. doi: 10.1038/eye.2016.192. Epub 2016 Aug 12.
Abstract
摘要
相似文献
1
Dexamethasone implant in diabetic macular edema.
Eye (Lond). 2016 Dec;30(12):1650. doi: 10.1038/eye.2016.192. Epub 2016 Aug 12.
2
Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
Int Ophthalmol. 2017 Feb;37(1):1-6. doi: 10.1007/s10792-016-0219-2. Epub 2016 Mar 11.
3
Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Eur J Ophthalmol. 2015 Mar-Apr;25(2):168-72. doi: 10.5301/ejo.5000523. Epub 2014 Oct 21.
4
A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
Retina. 2015 Aug;35(8):1604-14. doi: 10.1097/IAE.0000000000000533.
5
INTRAVITREAL DEXAMETHASONE IMPLANTATION IN PATIENTS WITH DIFFERENT MORPHOLOGICAL DIABETIC MACULAR EDEMA HAVING INSUFFICIENT RESPONSE TO RANIBIZUMAB.
Retina. 2018 May;38(5):986-992. doi: 10.1097/IAE.0000000000001648.
6
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
Retina. 2011 May;31(5):915-23. doi: 10.1097/IAE.0b013e318206d18c.
7
INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.
Retina. 2015 Jul;35(7):1429-35. doi: 10.1097/IAE.0000000000000490.
8
Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
Ophthalmic Res. 2017;58(3):125-130. doi: 10.1159/000477256. Epub 2017 Jul 14.
9
[Early efficacy of dexamethasone implant (OZURDEX) in diabetic macular edema: Real life study].
J Fr Ophtalmol. 2017 May;40(5):408-413. doi: 10.1016/j.jfo.2016.10.017. Epub 2017 Mar 21.
10
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Retina. 2016 Jan;36(1):131-6. doi: 10.1097/IAE.0000000000000616.
引用本文的文献
1
Noninvasive monitoring of suprachoroidal, subretinal, and intravitreal implants using confocal scanning laser ophthalmoscope (cSLO) and optical coherence tomography (OCT).
Int J Pharm. 2021 Sep 5;606:120887. doi: 10.1016/j.ijpharm.2021.120887. Epub 2021 Jul 14.
本文引用的文献
1
Dexamethasone implant in diabetic macular edema in real-life situations.
Eye (Lond). 2016 Dec;30(12):1650. doi: 10.1038/eye.2016.191. Epub 2016 Aug 12.
2
The Impact of Systemic Factors on Clinical Response to Ranibizumab for Diabetic Macular Edema.
Ophthalmology. 2016 Jul;123(7):1581-7. doi: 10.1016/j.ophtha.2016.03.038. Epub 2016 May 24.
3
Dexamethasone implant in diabetic macular edema in real-life situations.
Eye (Lond). 2016 Mar;30(3):426-30. doi: 10.1038/eye.2015.246. Epub 2015 Nov 27.
4
Changes in macular thickness after panretinal photocoagulation in patients with severe diabetic retinopathy and no macular edema.
Retina. 2010 May;30(5):756-60. doi: 10.1097/IAE.0b013e3181c701e0.
Zotero 插件